Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2024-04-26 | Alzinova | KALLELSE TILL ÅRSSTÄMMA I ALZINOVA AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-26 | Alzinova | NOTICE OF ANNUAL GENERAL MEETING IN ALZINOVA AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-26 | Alzinova | Styrelsen beslutar om en företrädesemission av aktier om cirka 34,4 MSEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-26 | Alzinova | The Board of Directors resolves on a rights issue of shares of approximately SEK 34.4 million | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-25 | Alzinova | Kristina Torfgård lämnar VD-posten på Alzinova AB i juli 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-25 | Alzinova | Kristina Torfgård leaves the CEO position at Alzinova AB in July 2024 | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Kristina Torfgård leaves the CEO position at Alzinova AB in July 2024Alzinova’s CEO Kristina Torfgård has informed the Board of Directors that she wishes to step down as CEO of the company. Kristina will continue to focus on completing the phase 1b clinical study and preparing Alzinova for a phase 2 study with ALZ-101 until she leaves her position on July 31, 2024. The Board of Directors will initiate the search for Kristina’s successor immediately. ”It has been a fantastic journey and I am very proud of what we at Alzinova have achieved during my time as CEO. With strong data from the phase 1b study and with upcoming important milestones, I am convinced that the company has an exciting future with the goal of offering a therapeutic vaccine for Alzheimer’s disease through strategic partnering. I look forward to following the company as an engaged shareholder in the future”, comments Kristina Torfgård, CEO Alzinova. Kristina has, with great commitment and success during her four and a half years as CEO of Alzinova, brought the company’s vaccine candidate ALZ-101 to a phase 1b clinical study. With Kristina’s leadership, ALZ-101 has completed part A1 of the clinical study with good results showing high safety and tolerability in patients, which is the primary objective of the phase 1b study. Alzinova has also, under Kristina’s leadership, initiated two extension parts of the phase 1b study with the aim of obtaining valuable information for a future phase 2 study. I would like to extend my and the boards’ warm gratitude to Kristina for her valuable work during the over four years she has been at Alzinova. Under Kristina’s leadership, the company has taken the development of ALZ-101 to the unique position it is today with a recently completed phase 1b study with excellent results. In parallel, the company’s project portfolio has been expanded and business activities intensified. We are now well positioned to successfully develop ALZ-101 further and find commercial partners. I wish Kristina the best of luck in her new position. The Board will now initiate the recruitment of a new CEO with the aim of ensuring a smooth succession”, comments Julian Aleksov, Chairman of the Board of Alzinova. |
||||
2024-04-22 | Alzinova | BioStock: Alzinovas CSO kommenterar nya analysdata för ALZ-101 i Alzheimers sjukdom | Pressreleaser | Visa Stäng |
|
||||
2024-04-11 | Alzinova | Alzinova: Fördjupad analys påvisar positiv trend för biomarkörer | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-11 | Alzinova | Alzinova: In-depth analysis shows positive trend in biomarkers | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-10 | Alzinova | BioStock: Alzinova når ytterligare milstolpe i Alzheimerstudie | Pressreleaser | Visa Stäng |
|
||||
2024-04-04 | Alzinova | Alzinova - Samtliga patienter i fas 1b-studiens förlängningsdel har fått sin sista dos | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-04 | Alzinova | Alzinova - All patients in the extension part of the phase 1b study have received their last dose | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-08 | Alzinova | Alzinova utser Erik Kullgren som interim CFO | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-08 | Alzinova | Alzinova appoints Erik Kullgren as interim CFO | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-05 | Alzinova | Alzinova presenterar på investerarträffar i mars | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-05 | Alzinova | Alzinova presents at investor meetings in March | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-04 | Alzinova | BioStock: Alzinova siktar på partnerskap för Alzheimerstudien | Pressreleaser | Visa Stäng |
|
||||
2024-02-29 | Penser Future by Carnegie | Penser Future by Carnegie: Alzinova - Huvudfokus för 2024 är att teckna ett partneravtal | Pressreleaser | Visa Stäng |
|
||||
2024-02-28 | Redeye | Redeye: Alzinova Q4 – With wind in the sails | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-28 | Alzinova | Alzinova publishes Year-end report 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-02-28 | Alzinova | Alzinova offentliggör bokslutskommuniké för 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-02-16 | Alzinova | BioStock: Alzinova får grönt ljus att öka dosen i Alzheimerstudie | Pressreleaser | Visa Stäng |
|
||||
2024-02-13 | Alzinova | Alzinova receives regulatory approval to evaluate a higher dose | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-13 | Alzinova | Alzinova får myndighetsgodkännande att utvärdera en högre dos | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-07 | Alzinova | Alzinova till BioStock: "Vi har ett starkt case med vår Alzheimerkandidat" | Pressreleaser | Visa Stäng |
|
||||
2024-01-30 | Alzinova | Alzinova: Primary analysis confirms positive phase 1b results with ALZ-101 against Alzheimer’s | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-30 | Alzinova | Alzinova: Primär analys bekräftar positiva fas 1b-resultat med ALZ-101 mot Alzheimers | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-08 | Alzinova | BioStock: Alzinova's CMO wants to bring forward a vaccine against Alzheimer's | Pressreleaser | Visa Stäng |
|
||||
2023-12-11 | Penser Future by Carnegie | Penser Future by Carnegie: Alzinova - Therapeutic Alzheimer's vaccine in the spotlight | Pressreleaser | Visa Stäng |
|
||||
2023-12-07 | Penser Future by Carnegie | Penser Future by Carnegie: Intervju med Alzinova - Carnegie Investment Bank - 7 dec 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-12-04 | Alzinova | BioStock: Alzinovas vd kommenterar positiva topline-data | Pressreleaser | Visa Stäng |
|
||||
2023-12-04 | Redeye | Redeye: Alzinova - Positive topline results | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-01 | Penser Future by Carnegie | Penser Future by Carnegie: Positiva topline-resultat från den kliniska fas Ib-studien - Alzinova | Pressreleaser | Visa Stäng |
|
||||
2023-12-01 | Alzinova | Alzinovas CFO avser gå i pension och Bolaget inleder rekryteringsprocessen för en efterträdare | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-01 | Alzinova | Alzinova's CFO plans for retirement and the Company initiates a recruitment process for a successor | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-29 | Alzinova | Alzinova meddelar positiva fas 1b-resultat med vaccinkandidaten ALZ-101 mot Alzheimers sjukdom | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-29 | Alzinova | Alzinova announces positive phase 1b results with the vaccine candidate ALZ-101 against Alzheimer's disease | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-21 | Penser Future | Penser Future: Terapeutiskt vaccin mot Alzheimers sjukdom i fokus - Alzinova AB | Pressreleaser | Visa Stäng |
|
||||
2023-11-20 | Alzinova | Alzinova presenterar på Erik Penser Banks Bolagsdag den 23 november | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-20 | Alzinova | Alzinova presents at Erik Penser Bank's Investor Day on November 23rd | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-06 | Alzinova | BioStock: Alzinova om förväntningarna inför BIO-Europe | Pressreleaser | Visa Stäng |
|
||||
2023-11-02 | Redeye | Redeye: Alzinova Q3 - All eyes on the readout | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-02 | Alzinova | Alzinova AB delårsrapport för januari - september 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-11-02 | Alzinova | Alzinova AB interim report January – September 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-10-24 | Alzinova | Alzinova engages Erik Penser Bank as liquidity provider | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-24 | Alzinova | Alzinova anlitar Erik Penser Bank som likviditetsgarant | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-05 | Alzinova | Alzinova deltar under hösten vid Europas största Life science-konferens och investerarträffar | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-05 | Alzinova | Alzinova will attend Europe's largest Life Science conference and investor meetings this fall | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-28 | Alzinova | BioStock: Alzinova säkrar regulatoriskt stöd från EMA | Pressreleaser | Visa Stäng |
|
||||
2023-09-26 | Alzinova | Alzinova receives positive response from the European Medicines Agency EMA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-26 | Alzinova | Alzinova erhåller positivt svar från European Medicines Agency EMA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-21 | Alzinova | Alzinova interviewed by Redeye in connection with World Alzheimer's Day | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-21 | Alzinova | Alzinova intervjuas hos Redeye i samband med World Alzheimer’s Day | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-11 | Alzinova | BioStock: Alzinovas vd sammanfattar 2023 och blickar framåt | Pressreleaser | Visa Stäng |
|
||||
2023-08-25 | Alzinova | Alzinova inleder samarbete med PolyPeptide | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-25 | Alzinova | Alzinova initiates collaboration with PolyPeptide | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-17 | Redeye | Redeye: Alzinova Q2 2023 - Proactive preparations | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-17 | Alzinova | Alzinova AB delårsrapport för januari - juni 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-17 | Alzinova | Alzinova AB interim report January – June 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-10 | Alzinova | BioStock: Alzinova meddelar positiva samtal med FDA | Pressreleaser | Visa Stäng |
|
||||
2023-08-09 | Alzinova | Alzinova progresses following positive Pre-IND meeting with FDA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-09 | Alzinova | Alzinova avancerar efter positivt Pre-IND-möte med FDA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-03 | Alzinova | Alzinova rekryterar Kirsten Harting som ny Chief Medical Officer | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-03 | Alzinova | Alzinova recruits Kirsten Harting as new Chief Medical Officer | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-16 | Alzinova | BioStock: Alzinovas vd om kontakterna med FDA och EMA - BioStock | Pressreleaser | Visa Stäng |
|
||||
2023-06-13 | Alzinova | Alzinova submits request for Pre-IND meeting with FDA and applies for EMA Scientific Advice | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-13 | Alzinova | Alzinova ansöker om Pre-IND möte med FDA och EMA Scientific Advice | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-30 | Alzinova | Bulletin from the annual general meeting of Alzinova AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-30 | Alzinova | Kommuniké från årsstämma i Alzinova AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-29 | Alzinova | Första patienten doserad i förlängningsdelen av fas 1b studien med ALZ-101 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-29 | Alzinova | First patient dosed in the extension part of the phase 1b study with ALZ-101 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-17 | Redeye | Redeye: Alzinova Q1 2023 - Promising clinical progress | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-17 | Alzinova | Alzinova AB interim report January – March 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-17 | Alzinova | Alzinova AB delårsrapport för januari - mars 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-10 | Alzinova | BioStock: Fortsatt robusta interimdata i Alzinovas Alzheimerstudie | Pressreleaser | Visa Stäng |
|
||||
2023-05-04 | Alzinova | Alzinova: New positive interim data from ongoing phase 1b study with vaccine candidate ALZ-101 – Initiates extension of the study | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-04 | Alzinova | Alzinova: Nya positiva interimdata från pågående fas 1b-studie med vaccinkandidaten ALZ-101 – Inleder förlängning av studien | Pressreleaser | Ladda ner | Visa Stäng |
|